{"id":"https://openalex.org/W4405048879","doi":"https://doi.org/10.1182/blood-2024-199097","title":"Ibromics: A Real-World Study of Clinical and Biological Parameters in Patients with Chronic Lymphocytic Leukemia (CLL) Treated in First Line with Single Agent Ibrutinib","display_name":"Ibromics: A Real-World Study of Clinical and Biological Parameters in Patients with Chronic Lymphocytic Leukemia (CLL) Treated in First Line with Single Agent Ibrutinib","publication_year":2024,"publication_date":"2024-11-05","ids":{"openalex":"https://openalex.org/W4405048879","doi":"https://doi.org/10.1182/blood-2024-199097"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2024-199097","doi":"https://doi.org/10.1182/blood-2024-199097","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2024-199097","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5051731658","display_name":"Cecilia Mu\u00f1oz\u2010Calleja","orcid":"https://orcid.org/0000-0003-4085-3115","observed_orcids":["https://orcid.org/0000-0003-4085-3115"]},"institutions":[{"id":"https://openalex.org/I4210130498","display_name":"Hospital Universitario de La Princesa","ror":"https://ror.org/03cg5md32","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210130498","https://openalex.org/I4210139293"]},{"id":"https://openalex.org/I4405259965","display_name":"Instituto de Investigaci\u00f3n Sanitaria del Hospital Universitario de La Princesa","ror":"https://ror.org/02zx68e15","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210139293","https://openalex.org/I4405259965"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Cecilia Mu\u00f1oz-Calleja","raw_affiliation_strings":["1Instituto De Investigaci\u00f3n Sanitaria Hospital Universitario De La Princesa, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Instituto De Investigaci\u00f3n Sanitaria Hospital Universitario De La Princesa, Madrid, Spain","institution_ids":["https://openalex.org/I4210130498","https://openalex.org/I4405259965"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041612097","display_name":"Jos\u00e9\u2010\u00c1ngel Hern\u00e1ndez\u2010Rivas","orcid":"https://orcid.org/0000-0003-4550-757X","observed_orcids":["https://orcid.org/0000-0003-4550-757X"]},"institutions":[{"id":"https://openalex.org/I4210165557","display_name":"Hospital Universitario Infanta Leonor","ror":"https://ror.org/05nfzf209","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210139293","https://openalex.org/I4210165557"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Jos\u00e9 \u00c1ngel Hern\u00e1ndez-Rivas","raw_affiliation_strings":["2Hospital Universitario Infanta Leonor. Universidad Complutense, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Hospital Universitario Infanta Leonor. Universidad Complutense, Madrid, Spain","institution_ids":["https://openalex.org/I4210165557"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054008156","display_name":"Francesc Bosch","orcid":"https://orcid.org/0000-0001-9241-2886","observed_orcids":["https://orcid.org/0000-0001-9241-2886"]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Francesc Bosch","raw_affiliation_strings":["3Hematology Department, Hospital Universitario Vall d'Hebron, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Hematology Department, Hospital Universitario Vall d'Hebron, Barcelona, Spain","institution_ids":["https://openalex.org/I4210127641"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089354375","display_name":"Laura Palomo","orcid":"https://orcid.org/0000-0003-3176-6271","observed_orcids":["https://orcid.org/0000-0003-3176-6271"]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]},{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Laura Palomo","raw_affiliation_strings":["4Experimental Hematology. Institut d'Oncologia Vall d'Hebron (VHIO), Hospital Universitari Vall d'Hebron, Barcelona, ESP"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Experimental Hematology. Institut d'Oncologia Vall d'Hebron (VHIO), Hospital Universitari Vall d'Hebron, Barcelona, ESP","institution_ids":["https://openalex.org/I4210127641","https://openalex.org/I4387155398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089770876","display_name":"Adri\u00e1n Mosquera Orgueira","orcid":"https://orcid.org/0000-0003-4838-6750","observed_orcids":["https://orcid.org/0000-0003-4838-6750"]},"institutions":[{"id":"https://openalex.org/I4210096311","display_name":"Complejo Hospitalario Universitario de Santiago","ror":"https://ror.org/00mpdg388","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210096311"]},{"id":"https://openalex.org/I4210148771","display_name":"Instituto de Investigaci\u00f3n Sanitaria de Santiago","ror":"https://ror.org/05n7xcf53","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210148771"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Adrian Mosquera Orgueira","raw_affiliation_strings":["5University Hospital of Santiago de Compostela, Department of Hematology, IDIS, SANTIAGO DE COMPOSTELA, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5University Hospital of Santiago de Compostela, Department of Hematology, IDIS, SANTIAGO DE COMPOSTELA, Spain","institution_ids":["https://openalex.org/I4210096311","https://openalex.org/I4210148771"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071390673","display_name":"Angel Ramirez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210133994","display_name":"Hospital Universitario Central de Asturias","ror":"https://ror.org/03v85ar63","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I2800212897","https://openalex.org/I4210133994","https://openalex.org/I4405258403"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Angel Ramirez","raw_affiliation_strings":["6Servicio de Hematolog\u00eda, Hospital Universitario Central de Asturias, Oviedo, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Servicio de Hematolog\u00eda, Hospital Universitario Central de Asturias, Oviedo, Spain","institution_ids":["https://openalex.org/I4210133994"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Ruben Fernandez Alvarez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210149758","display_name":"Hospital Universitario De Cabue\u00f1es","ror":"https://ror.org/03yw66316","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I2800212897","https://openalex.org/I4210149758","https://openalex.org/I4405258403"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Ruben Fernandez Alvarez","raw_affiliation_strings":["7Hospital de Cabue\u00f1es, Gij\u00f3n, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7Hospital de Cabue\u00f1es, Gij\u00f3n, Spain","institution_ids":["https://openalex.org/I4210149758"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017502227","display_name":"Ana Carla Oliveira","orcid":"https://orcid.org/0000-0002-1543-7243","observed_orcids":["https://orcid.org/0000-0002-1543-7243","https://orcid.org/0009-0008-2705-0784"]},"institutions":[{"id":"https://openalex.org/I4210087039","display_name":"Institut d'Investigaci\u00f3 Biom\u00e9dica de Bellvitge","ror":"https://ror.org/0008xqs48","country_code":"ES","type":"facility","lineage":["https://openalex.org/I157913058","https://openalex.org/I2802050225","https://openalex.org/I4210087039","https://openalex.org/I4210096656","https://openalex.org/I4210106543","https://openalex.org/I4210107147","https://openalex.org/I4210153292","https://openalex.org/I4387153040","https://openalex.org/I71999127"]},{"id":"https://openalex.org/I4210107147","display_name":"Institut Catal\u00e0 d'Oncologia","ror":"https://ror.org/01j1eb875","country_code":"ES","type":"government","lineage":["https://openalex.org/I4210107147"]},{"id":"https://openalex.org/I4210143012","display_name":"Duran i Reynals Hospital","ror":"https://ror.org/03qwghy04","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210143012"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Ana C Oliveira","raw_affiliation_strings":["8Institut Catala d'Oncologia (ICO) ICO Hospital Duran i Reynals, IDIBELL, Hospitalet de Llobregat, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"8Institut Catala d'Oncologia (ICO) ICO Hospital Duran i Reynals, IDIBELL, Hospitalet de Llobregat, Barcelona, Spain","institution_ids":["https://openalex.org/I4210087039","https://openalex.org/I4210107147","https://openalex.org/I4210143012"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047846906","display_name":"Paula Amat","orcid":"https://orcid.org/0000-0001-6321-4952","observed_orcids":["https://orcid.org/0000-0001-6321-4952"]},"institutions":[{"id":"https://openalex.org/I4210094406","display_name":"Hospital Cl\u00ednico Universitario de Valencia","ror":"https://ror.org/00hpnj894","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210094406"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Paula Amat Martinez","raw_affiliation_strings":["9Department of Hematology, Hospital Cl\u00ednico Universitario-INCLIVA, Valencia, ESP"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"9Department of Hematology, Hospital Cl\u00ednico Universitario-INCLIVA, Valencia, ESP","institution_ids":["https://openalex.org/I4210094406"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Alicia Serrano","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210094406","display_name":"Hospital Cl\u00ednico Universitario de Valencia","ror":"https://ror.org/00hpnj894","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210094406"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Alicia Serrano","raw_affiliation_strings":["10Department of Hematology, Hospital Cl\u00ednico Universitario-INCLIVA, Valencia, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"10Department of Hematology, Hospital Cl\u00ednico Universitario-INCLIVA, Valencia, Spain","institution_ids":["https://openalex.org/I4210094406"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048713337","display_name":"Ar\u00e1nzazu Garc\u00eda\u2010Grande","orcid":"https://orcid.org/0000-0001-5737-8918","observed_orcids":["https://orcid.org/0000-0001-5737-8918"]},"institutions":[{"id":"https://openalex.org/I4210105637","display_name":"Hospital Universitario Puerta de Hierro Majadahonda","ror":"https://ror.org/01e57nb43","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210105637","https://openalex.org/I4210139293"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Ar\u00e1nzazu Garc\u00eda-Grande","raw_affiliation_strings":["11Unidad de Citometria de Flujo y Separaci\u00f3n Celular. Hospital Universitario Puerta de Hierro Majadahonda, IDIPHISA, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"11Unidad de Citometria de Flujo y Separaci\u00f3n Celular. Hospital Universitario Puerta de Hierro Majadahonda, IDIPHISA, Madrid, Spain","institution_ids":["https://openalex.org/I4210105637"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018958627","display_name":"Ana Yeguas","orcid":"https://orcid.org/0000-0003-2320-7787","observed_orcids":["https://orcid.org/0000-0003-2320-7787"]},"institutions":[{"id":"https://openalex.org/I4210134045","display_name":"Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca","ror":"https://ror.org/03em6xj44","country_code":"ES","type":"facility","lineage":["https://openalex.org/I184999862","https://openalex.org/I4210099034","https://openalex.org/I4210134045"]},{"id":"https://openalex.org/I4210158561","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer","ror":"https://ror.org/04hya7017","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210158561"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Ana Yeguas","raw_affiliation_strings":["12Department of Hematology, University Hospital of Salamanca (HUS/IBSAL), CIBERONC, Salamanca, ESP"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"12Department of Hematology, University Hospital of Salamanca (HUS/IBSAL), CIBERONC, Salamanca, ESP","institution_ids":["https://openalex.org/I4210134045","https://openalex.org/I4210158561"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039369538","display_name":"Marta Crespo","orcid":"https://orcid.org/0000-0002-7732-7808","observed_orcids":["https://orcid.org/0000-0002-7732-7808"]},"institutions":[{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Marta Crespo","raw_affiliation_strings":["13Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"13Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain","institution_ids":["https://openalex.org/I4387155398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046656441","display_name":"Miguel Alcoceba","orcid":"https://orcid.org/0000-0002-3819-4846","observed_orcids":["https://orcid.org/0000-0002-3819-4846"]},"institutions":[{"id":"https://openalex.org/I184999862","display_name":"Universidad de Salamanca","ror":"https://ror.org/02f40zc51","country_code":"ES","type":"education","lineage":["https://openalex.org/I184999862"]},{"id":"https://openalex.org/I4210134045","display_name":"Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca","ror":"https://ror.org/03em6xj44","country_code":"ES","type":"facility","lineage":["https://openalex.org/I184999862","https://openalex.org/I4210099034","https://openalex.org/I4210134045"]},{"id":"https://openalex.org/I4210138819","display_name":"Centro de Investigaci\u00f3n del C\u00e1ncer","ror":"https://ror.org/04rxrdv16","country_code":"ES","type":"facility","lineage":["https://openalex.org/I134820265","https://openalex.org/I184999862","https://openalex.org/I4210138819"]},{"id":"https://openalex.org/I4210158561","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer","ror":"https://ror.org/04hya7017","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210158561"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Miguel Alcoceba","raw_affiliation_strings":["14Hospital Universitario de Salamanca. (HUS/IBSAL), CIBERONC, and Centro de Investigaci\u00f3n del C\u00e1ncer (CIC/USAL, Salamanca, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"14Hospital Universitario de Salamanca. (HUS/IBSAL), CIBERONC, and Centro de Investigaci\u00f3n del C\u00e1ncer (CIC/USAL, Salamanca, Spain","institution_ids":["https://openalex.org/I184999862","https://openalex.org/I4210134045","https://openalex.org/I4210138819","https://openalex.org/I4210158561"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023740017","display_name":"Blanca Ferrer Lores","orcid":"https://orcid.org/0000-0001-9452-7310","observed_orcids":["https://orcid.org/0000-0001-9452-7310"]},"institutions":[{"id":"https://openalex.org/I4210158373","display_name":"INCLIVA Health Research Institute","ror":"https://ror.org/059wbyv33","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210158373"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Blanca Ferrer Lores","raw_affiliation_strings":["15Hospital clinico Valencia - INCLIVA, Valencia, ESP"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"15Hospital clinico Valencia - INCLIVA, Valencia, ESP","institution_ids":["https://openalex.org/I4210158373"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039666272","display_name":"Jos\u00e9 Antonio Garc\u00eda Vela","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210105637","display_name":"Hospital Universitario Puerta de Hierro Majadahonda","ror":"https://ror.org/01e57nb43","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210105637","https://openalex.org/I4210139293"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Jos\u00e9 Antonio Garcia Vela","raw_affiliation_strings":["16Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"16Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain","institution_ids":["https://openalex.org/I4210105637"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040912403","display_name":"Luis Espinosa\u2010Hevia","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210105637","display_name":"Hospital Universitario Puerta de Hierro Majadahonda","ror":"https://ror.org/01e57nb43","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210105637","https://openalex.org/I4210139293"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Luis Espinosa-Hevia","raw_affiliation_strings":["17Servicio de Hematolog\u00eda y Hemoterapia, Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"17Servicio de Hematolog\u00eda y Hemoterapia, Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, Madrid, Spain","institution_ids":["https://openalex.org/I4210105637"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5115009462","display_name":"Celia Bolumburu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Celia Bolumburu","raw_affiliation_strings":["18Janssen Janssen-Cilag, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"18Janssen Janssen-Cilag, Madrid, Spain","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5143182215","display_name":"Miguel Jes\u00fas Villanueva Forero","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Miguel Villanueva Forero","raw_affiliation_strings":["19Janssen-Cilag, Madrid, ESP"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"19Janssen-Cilag, Madrid, ESP","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":19,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5000,"currency":"USD","value_usd":5000},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"144","issue":"Supplement 1","first_page":"6769","last_page":"6769"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-lymphocytic-leukemia","display_name":"chronic lymphocytic leukemia","score":0.9980000257492065},{"id":"https://openalex.org/keywords/ibrutinib","display_name":"ibrutinib","score":0.9959999918937683},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.8270000219345093},{"id":"https://openalex.org/keywords/immune-restoration","display_name":"immune restoration","score":0.7720000147819519},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.6660000085830688},{"id":"https://openalex.org/keywords/btk-inhibition","display_name":"BTK inhibition","score":0.7839999794960022},{"id":"https://openalex.org/keywords/lymphocyte-subsets","display_name":"lymphocyte subsets","score":0.8619999885559082},{"id":"https://openalex.org/keywords/cd38","display_name":"CD38","score":0.3310000002384186},{"id":"https://openalex.org/keywords/cd19","display_name":"CD19","score":0.4959999918937683},{"id":"https://openalex.org/keywords/cd20","display_name":"CD20","score":0.45100000500679016},{"id":"https://openalex.org/keywords/cd10","display_name":"CD10","score":0.3409999907016754},{"id":"https://openalex.org/keywords/cd5","display_name":"CD5","score":0.3400000035762787},{"id":"https://openalex.org/keywords/cd23","display_name":"CD23","score":0.36399999260902405},{"id":"https://openalex.org/keywords/cd22","display_name":"CD22","score":0.34200000762939453},{"id":"https://openalex.org/keywords/cd11c","display_name":"CD11c","score":0.32199999690055847},{"id":"https://openalex.org/keywords/cd123","display_name":"CD123","score":0.36500000953674316},{"id":"https://openalex.org/keywords/unmutated-ighv","display_name":"unmutated IGHV","score":0.6840000152587891},{"id":"https://openalex.org/keywords/17p-deletion","display_name":"17p deletion","score":0.8429999947547913},{"id":"https://openalex.org/keywords/tp53-mutation","display_name":"TP53 mutation","score":0.9169999957084656},{"id":"https://openalex.org/keywords/complex-karyotype","display_name":"complex karyotype","score":0.7879999876022339},{"id":"https://openalex.org/keywords/real-world-evidence","display_name":"real-world evidence","score":0.6299999952316284}],"concepts":[{"id":"https://openalex.org/C2779878957","wikidata":"https://www.wikidata.org/wiki/Q5984881","display_name":"Ibrutinib","level":4,"score":0.9493497610092163},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.728723406791687},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.7162798047065735},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5255471467971802},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.49583420157432556},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.4902954399585724},{"id":"https://openalex.org/C90059517","wikidata":"https://www.wikidata.org/wiki/Q423572","display_name":"Bruton's tyrosine kinase","level":4,"score":0.4878509044647217},{"id":"https://openalex.org/C61943457","wikidata":"https://www.wikidata.org/wiki/Q6046661","display_name":"Interim analysis","level":3,"score":0.4347561001777649},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3883407413959503},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.3817112445831299},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3526534140110016},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.09236249327659607},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2024-199097","doi":"https://doi.org/10.1182/blood-2024-199097","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2024-199097","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W6885040352","https://openalex.org/W4296468465","https://openalex.org/W3095395815","https://openalex.org/W4379346121","https://openalex.org/W4283321015","https://openalex.org/W3191745389","https://openalex.org/W2919004412","https://openalex.org/W2989381418","https://openalex.org/W4385698984","https://openalex.org/W1891620832"],"abstract_inverted_index":{"Background":[0],"Chronic":[1],"Lymphocytic":[2],"Leukemia":[3],"(CLL)":[4],"is":[5,96,132,590],"influenced":[6],"by":[7,22],"the":[8,12,15,20,24,28,46,66,69,88,100,113,119,137,160,180,191,198,342,456,460,530,543,596,617,622],"leukemic":[9],"microenvironment":[10,48],"and":[11,35,38,56,62,74,111,152,165,170,217,249,270,315,352,413,433,448,487,542,569,604],"competence":[13],"of":[14,27,68,93,103,115,124,136,162,173,193,231,280,347,355,366,385,392,459,500,532,545,550,562,585,616],"immune":[16,58,70,116,194,546],"system":[17],"(IS).":[18],"Treating":[19],"disease":[21],"restoring":[23],"anti-tumor":[25],"activity":[26],"patient's":[29],"IS":[30,597],"can":[31],"lead":[32],"to":[33,97,150,185,189,210,341,402,440,598,601,612,625],"sustained":[34],"deep":[36],"responses":[37],"reduce":[39],"side":[40],"effects.":[41],"Ibrutinib":[42],"elicits":[43],"changes":[44],"in":[45,72,85,126,202,205,237,257,325,339,421,465,509,535,552,577,621],"tumor":[47,603],"that":[49],"both":[50,567,602],"control":[51],"CLL":[52,73,105,148],"malignant":[53],"B-cells":[54],"proliferation":[55],"reestablish":[57],"surveillance,":[59],"through":[60],"BTK":[61],"ITK":[63],"inhibition.":[64],"Understanding":[65],"relevance":[67],"players":[71],"how":[75],"different":[76],"treatments":[77],"affect":[78],"them":[79],"would":[80],"have":[81],"a":[82,127,274,278,390,418,498,506,553,559,582,613],"direct":[83],"impact":[84],"successfully":[86],"managing":[87],"disease.":[89],"Aims":[90],"The":[91,295,345,363,382,556],"aim":[92],"this":[94,466],"study":[95,143,525],"comprehensively":[98],"analyze":[99],"baseline":[101,169,351,373,401],"characteristics":[102,541],"1L":[104,154],"patients":[106,200,225,239,259,330],"treated":[107],"with":[108,146,277,303,319,331,574,628],"single-agent":[109,356,533],"ibrutinib":[110,155,357,534,629],"investigate":[112],"dynamics":[114,192,544],"restoration":[117,547,561,589],"during":[118],"first":[120],"6":[121],"months":[122],"(6m)":[123],"treatment":[125,359,551],"real-world":[128,141,523],"setting.":[129,555],"Methods":[130],"This":[131,522,588],"an":[133,228,575],"interim":[134],"analysis":[135,161],"multicenter,":[138],"prospective,":[139],"non-interventional":[140],"evidence":[142],"IBROMICS.":[144],"Patients":[145],"active":[147],"according":[149],"iwCLL18":[151],"starting":[153,425],"were":[156,215,235,290,327],"included.":[157],"We":[158],"report":[159],"patients'":[163,540],"clinical":[164,554],"immunological":[166,348,618],"data":[167],"at":[168,288,372,400,438],"after":[171,353,378,408,452,548],"6m":[172,289,354,379,409,453,549],"treatment.":[174],"A":[175],"paired":[176],"comparison":[177,346],"(samples":[178],"from":[179,207,370,389,426],"same":[181],"patients)":[182],"was":[183,220,255,300,505],"used":[184],"evaluate":[186],"lymphocyte":[187],"subsets":[188],"assess":[190],"restoration.":[195],"Results":[196],"Of":[197],"91":[199],"recruited":[201],"42":[203],"centers":[204],"Spain":[206],"September":[208,211],"2022":[209],"2023,":[212],"57":[213],"(62.6%)":[214],"male,":[216],"median":[218,279,364,376,391,474,483,493,517],"age":[219],"71":[221],"years":[222],"(62-78).":[223],"87/88":[224],"(98.9%)":[226],"had":[227,263,267,273],"ECOG":[229],"status":[230],"0-1.":[232],"Baseline":[233],"comorbidities":[234],"present":[236],"81/91":[238],"(89.0%),":[240],"most":[241],"commonly":[242],"hypertension":[243],"(40/91,":[244],"44.0%),":[245],"dyslipidemia":[246],"(23/91,":[247],"25.3%),":[248],"diabetes":[250],"(20/91,":[251],"22.0%).":[252],"Unmutated":[253],"IGHV":[254,343],"reported":[256],"60/87":[258],"(69.0%),":[260],"14/82":[261],"(17.1%)":[262],"del(17p),":[264],"19/85":[265],"(22.4%)":[266],"mutated":[268],"TP53,":[269],"7/65":[271],"(10.8%)":[272],"complex":[275],"karyotype":[276],"3.5":[281],"cytogenetic":[282],"alterations.":[283],"Data":[284],"on":[285,539],"therapeutic":[286],"response":[287,297,308,313,624],"available":[291],"for":[292,630],"35":[293],"patients.":[294],"overall":[296],"rate":[298],"(ORR)":[299],"88.6%":[301],"(n=31),":[302],"25.7%":[304],"(n=9)":[305],"having":[306],"complete":[307],"(CR),":[309],"17.1%":[310],"(n=6)":[311],"partial":[312,560],"(PR),":[314],"45.7%":[316],"(n=16)":[317],"PR":[318],"lymphocytosis":[320],"(PR-L).":[321],"No":[322],"significant":[323,361,419],"differences":[324],"ORR":[326],"observed":[328],"between":[329,350],"or":[332],"without":[333],"del(17p)/TP53":[334],"mutations,":[335],"as":[336,338,592],"well":[337],"relation":[340],"status.":[344],"parameters":[349],"420mg":[358],"revealed":[360],"changes.":[362],"percentage":[365],"lymphocytes":[367,386,416,511],"decreased":[368,388],"significantly":[369],"87.1%":[371],"(Q1-Q3,":[374,396,406,428,431,435,442,450,472,481,491,515],"71.0-93.1%),":[375],"change":[377,475,484,494,518],"-19.2%":[380],"(p<0.0001).":[381],"absolute":[383,423],"number":[384],"also":[387],"66.2":[393],"cells":[394,404],"\u00d7109/L":[395,405],"19.4":[397],"-":[398],"106.4\u00d7109/L)":[399],"15.3":[403],"6.7-36.4\u00d7109/L)":[407],"(p<0.001).":[410],"CD3,":[411],"CD4,":[412],"CD8":[414,478],"T":[415,563,570],"showed":[417],"reduction":[420],"their":[422],"values,":[424],"3.8\u00d7109/L":[427],"3.0-4.1\u00d7109/L),":[429],"2.5\u00d7109/L":[430,434],"1.2-19.1\u00d7109/L),":[432],"1.1-14.3\u00d7109/L),":[436],"respectively,":[437],"baseline,":[439],"1.2\u00d7109/L":[441],"0.1-2.5\u00d710":[443],"9/L),":[444],"1.6\u00d710":[445],"9/L":[446],"(Q1-Q3,0.8-3.6),":[447],"1.3\u00d7109/L":[449],"0.6-2.9\u00d7109/L),":[451],"(p<0.01).":[454],"However,":[455],"relative":[457],"values":[458],"main":[461],"T-lymphocyte":[462],"subpopulations":[463],"increased":[464],"period,":[467],"including":[468,566],"CD4":[469,512],"(baseline":[470,479,489,513],"2.6%":[471],"1.5-6.3%),":[473],"+3.7%":[476],"(p<0.001)),":[477],"3.0%":[480],"1.1-4.4%),":[482],"+4.3%":[485],"(p<0.0001)),":[486],"gammadelta":[488],"1.5%":[490],"0.5-3.9%),":[492],"+1.0%":[495],"(p<0.005)),":[496],"indicating":[497],"recovery":[499],"these":[501,608],"cells.":[502],"Additionally,":[503,607],"there":[504],"notable":[507],"increase":[508,576],"naive":[510,578],"28.1%":[514],"13.8-40.1%),":[516],"+4.7%":[519],"(p<0.01)).":[520],"Conclusions":[521],"prospective":[524],"provides":[526],"valuable":[527],"insights":[528],"into":[529],"utilization":[531],"CLL,":[536],"providing":[537],"information":[538],"findings":[557,609],"indicate":[558],"cell":[564],"competence,":[565],"cytotoxic":[568],"helper":[571],"lymphocytes,":[572],"along":[573],"cells,":[579],"thus":[580],"suggesting":[581],"broader":[583],"repertoire":[584],"antigenic":[586],"response.":[587],"vital":[591],"it":[593],"may":[594,610],"enable":[595],"effectively":[599],"respond":[600],"infectious":[605],"antigens.":[606],"contribute":[611],"deeper":[614],"understanding":[615],"mechanisms":[619],"involved":[620],"improved":[623],"drug":[626],"combinations":[627],"CLL.":[631]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2024-12-06T00:00:00"}